SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied ...

The bank appointed HSBC Bank PLC, BofA Securities, Citigroup Global Markets Limited, J.P. Morgan Securities PLC, Kamco Investment Company, Mizuho International PLC, Standard Chartered Bank, and Warba ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. Tanya Fir, ...

SAB’s 9M 2025 net profit rises to SAR 6.41B; Q3 at SAR 2.14B 9 M 2025 SAB profit up 5% to SAR 4.3B in H1 2025; Q2 at SAR 2.1B 6 M 2025 SAB profit rises 5% to SAR 2.13B in Q1 2025 3 M 2025 SAB's 2024 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Morningstar analysts do not currently cover SZK, but with our powerful screener, you can find stocks in the same sector,industry, or style and filter on our unbiased ratings and valuation metrics.